Arbutus Biopharma Corp. (ABUS)
5.20
-0.01
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
5.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Debt to Equity Ratio : 0.014 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.014 |
| March 31, 2026 | 0.015 |
| December 31, 2025 | 0.0547 |
| September 30, 2025 | 0.0595 |
| June 30, 2025 | 0.0602 |
| March 31, 2025 | 0.0707 |
| December 31, 2024 | 0.0628 |
| September 30, 2024 | 0.0633 |
| June 30, 2024 | 0.0609 |
| March 31, 2024 | 0.0705 |
| December 31, 2023 | 0.0823 |
| September 30, 2023 | 0.084 |
| June 30, 2023 | 0.0804 |
| March 31, 2023 | 0.0799 |
| December 31, 2022 | 0.0917 |
| September 30, 2022 | 0.1005 |
| June 30, 2022 | 0.109 |
| March 31, 2022 | 0.1084 |
| December 31, 2021 | 0.1116 |
| September 30, 2021 | 0.1585 |
| June 30, 2021 | 0.2163 |
| March 31, 2021 | 0.1951 |
| December 31, 2020 | 0.221 |
| September 30, 2020 | 0.2386 |
| June 30, 2020 | 0.3506 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3095 |
| December 31, 2019 | 0.3072 |
| September 30, 2019 | 0.0415 |
| June 30, 2019 | 0.0221 |
| March 31, 2019 | 0.0214 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.0658 |
| September 30, 2017 | 0.0717 |
| June 30, 2017 | 0.0683 |
| March 31, 2017 | 0.0635 |
| December 31, 2016 | 0.0591 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Moderna, Inc. | 0.1904 |
| Insmed, Inc. | 0.9865 |
| Pfizer Inc. | 0.7418 |
| Gossamer Bio, Inc. | -0.4261 |
| Legend Biotech Corp. | 0.2263 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 274.02M |
| Total Liabilities (Quarterly) | 15.29M |
| Shareholders Equity (Quarterly) | 258.73M |
| Current Ratio | 81.42 |
| Net Debt Paydown Yield | 0.04% |